China Pharmaceutical Industry to grow at 12.5% CAGR by 2014

Emerging Markets Direct (EMD) released the latest China Pharmaceutical Industry Report1H11. China Pharmaceutical market has been growing rapidly as the fourth-largest market in the world in terms of size.  As one of the “pharmerging markets” in BRIC, the industry is expected to grow at 12.5% CAGR during 2009 – 2014. Backed by vast pool of talent, low-cost manufacturing capabilities, and huge market potential, it has attracted several global drug giants to outsource their R&D and invest in China.

While the market size of China Pharmaceuticals in 2009 was USD46.15billion, its overall health expenditure was among the lowest in the world comparable to that of Morocco, India or Saudi Arabia. In 2009, China’s overall health expenditure was at USD230.7 billion, a 4.7% of total GDP.  The industry is well-known for its fragmented nature with 7,664 enterprises in 2009, out of which local domestic enterprises account for 70% of industry sales.

Government policies change the landscape of pharmaceutical industry in China. A three-year health care reform was introduced in 2009 attempting to increase medical insurance coverage, upgrade grassroots medical institution and set up the basic medicine system.  These gave a push to the generic pharmaceuticals with measures taken to curb over-prescription of unnecessary drugs. As a matter of fact, high-end drug distributors would be encouraged to consolidate in order to stay competitive.

Over-the-counter pharmaceuticals market is a growing segment in the Chinese pharmaceutical industry and set to double its market share by 2014. Backed by the aging population, increasing disposable income levels, and growth in the awareness of health care. Our analysts expect Over-the-counter purchases to increase along with the growth in the pharmaceutical industry as a whole.  Facing the tough competition from hospitals, the market is set to diversify with vitamins, minerals and supplements leading the growth of this segment.

Generic Drugs market will boom for the next 4 years to come as expiring blockbuster drug patents cause a surge in generic drug production. What’s more, Generic segment remains attractive to foreign investments, where multinational companies merge and acquire generic drug companies to compensate for the loss of income from expiring patents. Our analysts think that generic segment will capture a larger consumer base owing to the health-care subsidy put forward by Chinese government.

]]>

What are the prevailing problems in the pharmaceutical industry? How is the development of Traditional Chinese Medicine market? What are the competitive advantages of China pharmaceutical research? How does the condition of patent law and intellectual property rights affect the industry? What are the trends and outlook of the China pharmaceutical industry? Which are the top 100 Chinese Pharmaceutical Enterprises in 2009? How about the SWOT analysis of China Pharmaceutical market?

The answers are here in our latest in our latest number.  Complete with full analysis of key players including:

-Harbin Pharmaceutical Group Co.Ltd.
-Northeast Pharmaceutical Co.Ltd.
-North China Pharmaceutical Co. Ltd.
-Beijing Double-Crane Pharmaceutical Co.Ltd.

Profit now from our China Pharmaceutical Industry Report1H11

1.1      Industry Overview
1.1.1  Structure of China’s Pharmaceutical Industry
1.1.2  Industry Size And Value
1.2      Industry Production
1.3      Government Policies
1.3.1  Healthcare Reform Policy
1.3.2  11th Five-Year Plan
1.3.3  Intellectual Property Rights (IPR)
1.3.4  Administrative Protection
1.4      Pharmaceutical Industry Issues
1.5      Global Pharmaceutical Industry Trends 

2.1     Traditional Chinese Medicine (TCM) Market
2.2     Over-The-Counter (OTC) Pharmaceuticals Market
2.3     Generic Drugs Market
2.4     Research and Development (R&D)
2.4.1 Competitive Advantages In China Pharmaceutical Research
2.5     Imports and Exports
2.6     Merger & Acquisitions (M&A) of Companies
2.7     Market Outlook

3.1     Leading Players
3.1.1  Harbin Pharmaceutical Group Co., Ltd.
3.1.2  Northeast Pharmaceutical Co., Ltd. (NPC)
3.1.3  North China Pharmaceutical Co., Ltd. (NCP)
3.1.4 Beijing Double-Crane Pharmaceutical Co., Ltd. (BDCP)
3.2     Comparative Matrix
3.3     Top 100 Pharmaceutical Enterprises in China
3.4     SWOT Analysis of the Pharmaceutical Market In China

Table 1: Summary of Chinese Pharmaceutical Market in 2009
Table 2: List of major drug patent expiry from 2010 to 2011
Table 3: Harbin Pharmaceutical Group  Co., Ltd.: Financial Highlights 2007-2009
Table 4: Northeast Pharmaceutical Co., Ltd.: Financial Highlights 2007-2009
Table 5: North China Pharmaceutical Co., Ltd.: Financial Highlights 2007-2009
Table 6: Beijing Double-Crane Pharmaceutical Co., Ltd.: Financial Highlights 2007-2009
Table 7: Financial Highlights of the Leading Players 2008-2009
Table 8: Top 100 Chinese Pharmaceutical Enterprises in 2009

Chart 1: Gross Industrial Output of Medical and Pharmaceutical Products 2006-2009
Chart 2: No of Pharmaceutical Enterprises In China 2005-2009
Chart 3: 2009-2011Healthcare Reform
Chart 4: Global Pharmaceutical Market Size 2005-2009
Chart 5: OTC Pharmaceuticals Market Value 2005-2009
Chart 6: Total OTC Sales in 2009 by Breakdown
Chart 7: Import and Exports of Pharmaceuticals 2006-2009
Chart 8: China Pharmaceutical Market Projections (excl. HK) 2009-2014(f)

Emerging Markets Direct is the online research store from ISI Emerging Markets, a Euromoney Institutional Investor Company. We deliver in-house industry research report, industry analysis and data vital to support all kinds of business decision, academic and research purposes. Our flagship product – Emerging Markets Direct Report covers the top 20 industry sectors of India, China, Malaysia, Thailand, Indonesia, Vietnam and Indonesia. ISI Emerging Markets in-house analysts crunch the numbers from our proprietary CEIC databases and combine the results with on-the ground industry insight. The result is reliable, hard-to-get industry data, analysis and insight. Previously available only to subscribers of the ISI Emerging Markets Information Service, Emerging Market Direct reports are available now at our online research store. Our Other products are: Dealwatch,CEIC snapshots, CEIC datatalk, Intellinews. To view our full catalogue of products, please visit http://www.emergingmarketsdirect.com

Emerging Markets Direct
website: http://www.emergingmarketsdirect.com
email: press@emergingmarketsdirect.com

Be My Friend – www.myspace.com Gwen Olsen is a woman who use to be a pharmaceutical sales rep for 15 years until her niece killed herself while taking antidepressants. Gwen has more… written a book called, “Confessions of an Rx Drug Pusher” www.gwenolsen.com http www.myspace.com
Video Rating: 4 / 5

How to start a career in pharmaceutical sales

Pharmaceutical sales jobs are the most rewarding and sought after career in sales. One of the most common reasons that people pursue such careers is that they offer flexibility, the ability to manage your own schedule and territory, the ability to travel all over the world in the most exotic places with all the expenses paid by the company, and above all, salaries and bonuses that range between ,000 and 0,000 yearly. However, landing a job as a pharmaceutical sales representative requires quite a dedication and, most of all, love for the profession.

When you get interviewed for a pharmaceutical sales job, most likely, the first question you will be asked is “Why are you interested in pursuing a career in pharmaceutical sales”. This is a basic question for any type of job interview. Employers always begin an interview with “why are you interested in” and this is a straightforward question that requires a clear-cut answer.

First of all, as you would have answered for any other job position related to sales, the proper answer is that you love being a salesperson. If you already have an experience as a salesperson you should definitely mention it with examples, how you did the sale, how you convinced the customer into buying the product. In effect, you sell yourself to the employer during the interview. Without saying too much about yourself, you show you are an energetic, motivated and enthusiastic salesperson by telling the story of a previous sale that you have accomplished.

Then, you can explain why you think a career in pharmaceutical sales is right for you. This answer is two-fold. It involves both the characteristics of the pharmaceutical industry that would probably induce any salesperson to pursue a career and your personal traits that make you suitable for such a profession. Pharmaceutical industry is dynamic and demonstrates constant growth that offers to pharmaceutical sales professionals enormous opportunities for professional and personal growth. If you have spend some time in the field with a pharmaceutical sales representative to see first-hand what these people do, you should put it forward in the interview.

If you have decided to pursue a career in pharmaceutical sales after having done a thorough research in the field, you should explain it to the potential employer. Looking for this particular job for six months or more, will mean that you really feel like doing this job and you are a persistent individual that has specific career goals. Employers love to see candidates who are certain about their career objectives and feel like they are the right person for a particular job.

Overall, what you should have in mind when pursuing a career in the pharmaceutical sector is that pharmaceutical sales jobs reward knowledge, and tenacity. As a pharmaceutical sales representative you would spend most of your day on the road, visiting pharmacists, physicians, and hospital personnel to promote your company’s products and your sales volume. For every new product, you would spend a lot of time to learn its features and this would be like taking a pharmacology course. You would have to be familiar with the industry statistics, competition developments, and global data on a weekly basis. Admittedly, a career in pharmaceutical sales is a high-rewarding job, but it also requires a great deal of dedication, and readiness to make sacrifices for your career.

Written by Christina Pomoni
Investment Advisor – Freelancer Writer

Find More Pharmaceutical Articles